Is Neuehealth Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSE: NEUE) stock is to Hold NEUE stock.
Out of 1 analyst, 0 (0%) are recommending NEUE as a Strong Buy, 0 (0%) are recommending NEUE as a Buy, 1 (100%) are recommending NEUE as a Hold, 0 (0%) are recommending NEUE as a Sell, and 0 (0%) are recommending NEUE as a Strong Sell.
What is NEUE's revenue growth forecast for 2024-2024?
(NYSE: NEUE) Neuehealth's forecast annual revenue growth rate of 24.93% is forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 6.82%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.23%.
Neuehealth's revenue in 2024 is $1,160,802,000.
In 2024, NEUE is forecast to generate $11,680,409,889 in revenue, with the lowest revenue forecast at $11,680,409,889 and the highest revenue forecast at $11,680,409,889.
What is NEUE's forecast return on assets (ROA) for 2024-2025?
(NYSE: NEUE) forecast ROA is 6.84%, which is lower than the forecast US Healthcare Plans industry average of 7.75%.
What is NEUE's Price Target?
According to 1 Wall Street analyst that have issued a 1 year NEUE price target, the average NEUE price target is $8.00, with the highest NEUE stock price forecast at $8.00 and the lowest NEUE stock price forecast at $8.00.
The Wall Street analyst predicted that Neuehealth's share price could reach $8.00 by Mar 13, 2025. The average Neuehealth stock price prediction forecasts a potential upside of 23.84% from the current NEUE share price of $6.46.
What is NEUE's forecast return on equity (ROE) for 2024-2025?
(NYSE: NEUE) forecast ROE is -6.63%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.